Literature DB >> 19705087

Antigenic structure of the human muscle nicotinic acetylcholine receptor main immunogenic region.

Jie Luo1, Jon Lindstrom.   

Abstract

The main immunogenic region on the alpha1 subunits of muscle nicotinic acetylcholine receptors provokes half or more of the autoantibodies in myasthenia gravis and its animal model. Many of these autoantibodies depend on the native conformation of the receptor for their ability to bind with high affinity. We mapped this region and explained the conformation dependence of its epitopes by making chimeras in which sequences of human muscle alpha1 subunits were replaced in human neuronal alpha7 subunits or Aplysia acetylcholine binding protein. These chimeras also revealed that the main immunogenic region can play a major role in promoting conformational maturation and, consequently, assembly of receptor subunits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705087      PMCID: PMC2808457          DOI: 10.1007/s12031-009-9271-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  19 in total

1.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.

Authors:  Alexandre Kuryatov; Jennifer Onksen; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2008-04-01       Impact factor: 4.436

3.  Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor.

Authors:  B Conti-Tronconi; S Tzartos; J Lindstrom
Journal:  Biochemistry       Date:  1981-04-14       Impact factor: 3.162

4.  The regulation of acetylcholine receptor expression in mammalian muscle.

Authors:  J P Merlie; R Sebbane; S Gardner; E Olson; J Lindstrom
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

Review 5.  Acetylcholine receptors and myasthenia.

Authors:  J M Lindstrom
Journal:  Muscle Nerve       Date:  2000-04       Impact factor: 3.217

6.  Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.

Authors:  S J Tzartos; J M Lindstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

Review 7.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

8.  Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies.

Authors:  S J Tzartos; M E Seybold; J M Lindstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

Review 9.  RIC-3: a nicotinic acetylcholine receptor chaperone.

Authors:  N S Millar
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

10.  Role of the N-terminal alpha-helix in biogenesis of alpha7 nicotinic receptors.

Authors:  Mar Castillo; José Mulet; Marcos Aldea; Susana Gerber; Salvador Sala; Francisco Sala; Manuel Criado
Journal:  J Neurochem       Date:  2008-01-23       Impact factor: 5.372

View more
  4 in total

1.  A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts.

Authors:  Kerrie Vaughan; Yohan Kim; Alessandro Sette
Journal:  Autoimmune Dis       Date:  2012-12-02

Review 2.  Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

Review 3.  Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies.

Authors:  Hans Frykman; Pankaj Kumar; Joel Oger
Journal:  Front Neurol       Date:  2020-12-09       Impact factor: 4.003

Review 4.  Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.